When should I have cervical screening and the HPV vaccine in India?

What is the difference between a Pap test, HPV test and VIA?

A Pap test examines cells collected from the cervix. An HPV test checks for high-risk types of the virus. Visual inspection with acetic acid, or VIA, is an examination of the cervix used in India’s public screening programme. These are different methods, so their follow-up schedules should not be treated as interchangeable.

An abnormal screening result does not necessarily mean cancer. It means that the next step—repeat testing, colposcopy or another assessment—must be decided from the exact result. Bring the full report rather than only a message saying “positive”.

At what age does routine screening begin in India?

The National Health Mission’s current medical-officer module describes VIA screening for women aged 30–65 once every five years. This is a public-programme schedule for people without symptoms. It does not mean everyone needs a Pap test every five years, nor that symptoms should wait until age 30.

Where HPV testing or cytology is used, the interval depends on that method, previous results and the guideline followed. WHO recommends HPV-based screening from age 30 in the general population, usually at five- to ten-year intervals, with an earlier and more frequent pathway for women living with HIV. Ask your doctor to write down your test type and next due date.

Who needs a different screening plan?

Previous abnormal results, treatment for cervical precancer, HIV or other immune suppression can change the plan. Whether screening continues after hysterectomy depends partly on whether the cervix remains and why surgery was performed. Do not stop screening simply because periods have stopped.

Screening is intended for people without symptoms. Bleeding after sex, unexpected bleeding between periods, blood-stained discharge or bleeding after menopause needs clinical assessment even if the last screening result was normal. A screening appointment alone may not address the cause of these symptoms.

What is India’s current HPV vaccination programme?

India launched its national HPV vaccination programme on 28 February 2026. The programme offers a single dose of quadrivalent HPV vaccine to eligible 14-year-old girls at government facilities. This is a specific public-health programme, not a statement that one dose is the correct schedule for every age, product or health condition.

Check current eligibility through the public programme and take any existing vaccine record. Do not assume that a previously vaccinated person needs another dose without review. This page does not claim that vaccination is administered at this practice or quote a private fee.

What schedule applies outside that programme?

WHO’s 2022 guidance permits one or two doses for girls aged 9–14 and women aged 15–20, and two doses six months apart for women older than 21. Immunocompromised people need at least two doses and, where feasible, three. These recommendations must be applied alongside India’s programme rules and the particular vaccine’s approved instructions.

Individual schedules in India can therefore differ from the national single-dose programme. FOGSI materials discuss product-specific and reduced-dose approaches. Ask the vaccinating clinician to confirm the product, number of doses and interval in writing. An interrupted series should be reviewed from the recorded doses rather than automatically restarted or mixed without advice.

Can an adult or someone already sexually active benefit?

Vaccines work best before exposure, but prior sexual activity does not automatically rule out benefit against types not already acquired. The decision for an adult depends on age, previous vaccination and likely benefit. The vaccine does not treat an existing HPV infection or an abnormal cervical result.

Vaccination is deferred during pregnancy. Tell the vaccinating clinician about pregnancy, immune suppression, significant allergies and previous reactions. Ask about observation after the injection and how adverse symptoms should be reported. Marriage status should not be used as a substitute for an individual medical discussion.

How can I prepare for the visit?

Bring screening reports, any colposcopy or treatment records, vaccine dates and information about medicines that affect immunity. You can ask for the examination to be explained, request a chaperone and discuss discomfort or anxiety before it begins.

Before leaving, confirm how results will reach you, who will explain an abnormal result and when the next test or vaccine dose is due. Keep these details with your health records; a clear follow-up plan matters as much as having the initial test.

What should I ask at my consultation?

Questions to ask at your consultation

• Which screening method am I having and why?
• When is my next test due if the result is normal?
• Does my history change the routine schedule?
• Which vaccine product and schedule fit my age and health?
• Who will contact me about results and follow-up?

What else do patients ask?

Related care: Gynaecology consultations.